Table 4. Association between PACE and post-discharge mortality in patients with and without CVD.

Subjects	Unadjusted HR (95% CI)	P-value	Adjusted HR (95% CI)	P-value
*Adjusted for age, male, body mass index, diabetes mellitus, hypertension, dyslipidemia, chronic kidney disease, coronary artery disease, atrial fibrillation, heart failure, stroke, hospitalization period related to COVID-19 pandemic, hemoglobin, HbA1c, serum creatinine, albumin, troponin I, left ventricular ejection fraction. **Adjusted for * covariates except for coronary artery disease, atrial fibrillation, heart failure and stroke. Peripheral artery disease was not analyzed due to small number. CVD: cardiovascular disease; PACE: perioperative adverse cardiac event.
CVD group (n = 133)*	2.81 (1.39–5.68)	0.004	1.20 (0.41–3.50)	0.735
Non–CVD group (n = 313)**	2.27 (1.26–4.09)	0.006	2.69 (1.35–5.38)	0.005